Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 89.23% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | -54.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -54.47% |
| Sep 27, 2025 | 65.11% |
| Jun 28, 2025 | -13.13% |
| Mar 29, 2025 | 64.03% |
| Dec 28, 2024 | -27.78% |
| Sep 28, 2024 | 162.09% |
| Jun 29, 2024 | 14.84% |
| Mar 30, 2024 | -34.96% |
| Dec 30, 2023 | 137.79% |
| Sep 30, 2023 | 38.91% |
| Jul 1, 2023 | -88.17% |
| Apr 1, 2023 | -31.10% |
| Dec 31, 2022 | -24.72% |
| Sep 24, 2022 | 34.41% |
| Jun 25, 2022 | -36.66% |
| Mar 26, 2022 | 51.32% |
| Dec 25, 2021 | -34.46% |
| Sep 25, 2021 | 71.64% |
| Jun 26, 2021 | -155.48% |
| Mar 27, 2021 | 123.05% |